A 90-day subchronic toxicity study of beta-calcium pyrophosphate in rat

Drug and Chemical Toxicology

Volumn 32, Issue 3, 2009, Pages 277-282

  Lee, Jae Hyup ^a   Chang, Bong Soon ^b   Ryu, Hyun Seung ^c   Lee, Choon Ki ^b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Sunkyong Industries   (South Korea)

Author keywords

Beta calcium pyrophosphate; Rat; Subchronic toxicity

Indexed keywords

CALCIUM PYROPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE GRAFT; BONE PROSTHESIS; CONTROLLED STUDY; FEMALE; FLUID INTAKE; HISTOPATHOLOGY; MALE; NONHUMAN; ORGAN WEIGHT; RAT; TOXICITY TESTING; ANIMAL; BLOOD EXAMINATION; CLINICAL CHEMISTRY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; ORAL DRUG ADMINISTRATION; ORGAN SIZE; SPRAGUE DAWLEY RAT; URINALYSIS; VISUAL SYSTEM EXAMINATION;

ANIMALIA; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CALCIUM PYROPHOSPHATE; CLINICAL CHEMISTRY TESTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HEMATOLOGIC TESTS; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; URINALYSIS;

EID: 70349906673     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540902882226     Document Type: Article

References (10)

1. Dias, A.G., Lopes, M.A., Gibson, I.R., Santos, J.D. (2003). In vitro degradation studies of calcium phosphate glass ceramics prepared by controlled crystallization. J Non-Cryst Solids 330:81-89.
2. Ducheyne, P. (1987). Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res 21:219-236.
3. Kitsugi, T., Yamamuro, T., Nakamura, T., Kotani, S., Kokubo, T., Takeuchi, H. (1993). Four calcium phosphate ceramics as bone substitutes for non-weight-bearing. Biomaterials 14:216-224.
4. Kitsugi, T., Yamamuro, T., Nakamura, T., Oka, M. (1995). Transmission electron microscopy observations at the interface of bone and four types of calcium phosphate ceramics with different calcium/phosphorus molar ratios. Biomaterials 16:1101-1107.
5. Lee, J.H., Lee, D.H., Ryu, H.S., Chang, B.S., Hong, K.S., Lee, C.K. (2003). Porous beta-calcium pyrophosphate as a bone graft substitute in a canine bone defect model. Key Eng Mater 240-242:399-402.
6. Lee, J.H., Ryu, H.S., Lee, D.S., Hong, K.S., Chang, B.S., Lee, C.K. (2005). Biomechanical and histomorphometric study on the bone-screw interface of bioactive ceramic-coated titanium screws. Biomaterials 26:3249-3257.
7. Rosenthal, A.K. (2000). Formation of calcium pyrophosphate crystal: biologic implications. Curr Opin Rheumatol 12:219-222.
8. Silcox, D.C., McCarty, D.J. (1974). Elevated inorganic pyrophosphate concentration in synovial fluid in osteoarthritis and pseudogout. J Lab Clin Med 83:518-531.
9. Tancred, D.C., McCormack, B.A., Carr, A.J. (1998). A quantitative study of the sintering and mechanical properties of hydroxyapatite/phosphate glass composites. Biomaterials 19:1735-1743.
10. U.S. FDA. (2006). Part 182-substances generally recognized as safe. Section 182.8223-calcium pyrophosphate. In: Code of Federal Regulations (CFR) Title 21-Food and Drugs (U.S. Food and Drugs Administration) (p 478). Washington, DC: U.S. Government Printing Office (GPO).